UBC Medical Indonesia Tbk. vs Tigaraksa Satria Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Tigaraksa Satria Tbk. trades at Rp4,840 (market cap 4.34T, 1.4K 24h volume). The key difference: Tigaraksa Satria Tbk. is far larger — about 7.5× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 1.4K). Which is the better fit depends on your goals.
| LABS | TGKA | |
|---|---|---|
Market Cap | 576.7B | 4.34T |
Volume | 3.48M | 1.4K |
Lot | 34.82K | 14 |
Turnover | 522.79M | 6.74M |
Average Price | 150.13 | 4,817.14 |
Value | 522.79M | 6.74M |
Indicative Equilibrium Price | 148 | — |
Indicative Equilibrium Volume | 350 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Tigaraksa Satria Tbk (the Company) was established in Jakarta based on notarial deed No. 35 of M.M.I. Wiardi, S.H., dated November 17, 1986. PT. Tigaraksa Satria is a distributor of Nutrition, Chemicals, Cosmetic, Books, Garments and other consumer goods. Founded in 1987 as a subsidiary of PT. Tigaraksa, the company handles the dosmetic distribution products for more than 20 pricipals.
Read more on TGKA →